alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
Published 2 years ago • 2.4K plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
2:33
challenges with neoadjuvant endocrine therapy in breast cancer
-
1:27
treating er breast cancer patients with endocrine therapy resistance
-
6:23
alternate: fulvestrant and/or anastrozole in er her2- postmenopausal breast cancer
-
1:11
an unanswerable question? adjuvant and neoadjuvant treatment of breast cancer
-
1:42
her2dx and pcr in her2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
-
7:01
neoadjuvant hormonal treatment for luminal breast cancer: rationale, evidence and outcome
-
1:55
dr. judy boughey on neoadjuvant endocrine therapy in breast cancer
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
1:47
evaluating the role of neoadjuvant endocrine therapy in breast cancer
-
1:51
ameera-3: serd for er her2- breast cancer
-
1:36
dr. holmes on neoadjuvant endocrine therapy in breast cancer
-
0:50
serds for patients with er /her2- breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
57:06
neoadjuvant endocrine therapy in breast cancer
-
6:09
ki-67 index after neoadjuvant et as a prognostic biomarker for hr /her2- early breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer